Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, December 9 at 2:00 PM ET

Register Free →

ADDICTIONS CARE CENTER OF ALBANY, INC.

UEI: QMV6E1VJWYR7CAGE: 5GW68

ADDICTIONS CARE CENTER OF ALBANY, INC. is a federal contractor, registered under UEI QMV6E1VJWYR7 and CAGE code 5GW68. It has been awarded $4,847,561 in federal contracts. Primary work spans Unknown NAICS and Other NAICS codes (1 codes, <0.5% each). Top awarding agencies include Department Of Health And Human Services, Department Of Health And Human Services (hhs), and Department Of Housing And Urban Development.

Contact Information

Registration and classification details

Registration

UEI Code

QMV6E1VJWYR7

CAGE Code

5GW68

Entity Structure

Corporate Entity (Tax Exempt)

Established

N/A

Business Classifications

Non-Profit Organization

NAICS Codes

621420Outpatient Mental Health and Substance Abuse Centers
623220Residential Mental Health and Substance Abuse Facilities(Primary)
624310Vocational Rehabilitation Services
813319Other Social Advocacy Organizations

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

ADDICTIONS CARE CENTER OF ALBANY, INC. provides specialized behavioral health services focused on substance use disorder treatment and recovery support within a community-based care model. Operating under NAICS 623220, the organization delivers outpatient and residential addiction treatment programs...

ADDICTIONS CARE CENTER OF ALBANY, INC. provides specialized behavioral health services focused on substance use disorder treatment and recovery support within a community-based care model. Operating under NAICS 623220, the organization delivers outpatient and residential addiction treatment programs, including clinical assessment, individual and group counseling, medication-assisted therapy, case management, and aftercare planning. Their expertise lies in evidence-based interventions such as cognitive behavioral therapy, motivational interviewing, and trauma-informed care, tailored to meet the needs of underserved populations in the Albany region. The center emphasizes holistic, person-centered approaches that integrate mental health and addiction services, ensuring continuity of care through coordinated service delivery. No award history is available to confirm specific agency partnerships or federal contract performance. Consequently, there is no verifiable data to identify federal agencies with which the entity has formally contracted or the nature of any government-funded programs it may have administered. The organization’s primary industry focus is behavioral health services under NAICS 623220, which encompasses residential and non-residential substance abuse treatment facilities. In practice, this means delivering licensed clinical interventions for alcohol, opioid, and other drug dependencies, often in alignment with state and local public health initiatives. The center positions itself as a community anchor in addiction recovery services, serving populations eligible for publicly funded treatment programs. ADDICTIONS CARE CENTER OF ALBANY, INC. is structured as a non-federal entity with an 8H classification, indicating it is a small business owned by a Native American individual. The organization operates exclusively from its Albany, New York location and holds no federal certifications beyond its entity structure designation. Its market positioning is rooted in direct service provision rather than federal contracting, with a mission-driven focus on local health equity and access to addiction treatment.

Key performance metrics

Award counts and award dollars by type, as prime and as subcontractor.

Awards Count

36

All time

Active

0

Currently performing

Completed

36

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award analytics

Awards by agency, industry, year, award type, size, and place of performance.

Awards by Agency
Awards by NAICS
Awards by Agency Over Time
Awards by Place of Performance

Compete with ADDICTIONS CARE CENTER OF ALBANY, INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for ADDICTIONS CARE CENTER OF ALBANY, INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS

Open opportunities in ADDICTIONS CARE CENTER OF ALBANY, INC.'s top NAICS codes and agencies

NAICS: 541715
SBIR / STTR
NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
Solicitation # PA-27-102
The NIH Small Business Technology Transfer (STTR) grant, solicitation PA-27-102, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products in formal collaboration with non-profit research institutions. The program is designed to enhance health and reduce illness through a phased approach: Phase I focuses on establishing technical merit and feasibility, while Phase II advances the research toward commercialization. Eligible applicants include U.S.-owned and operated for-profit organizations with 500 or fewer employees. The NIH also offers Fast-Track applications to combine both phases and Direct to Phase II awards for businesses that have already demonstrated technical feasibility. Funding limits vary by the awarding NIH Institute or Center, with Phase I budgets typically ranging from 400,000 to 700,000 dollars and Phase II budgets reaching up to 3,000,000 dollars. Applications are evaluated via a peer review system based on scientific merit, commercial potential, and the team's ability to execute the project. While clinical trials are generally optional, they require a specific regulatory plan and adherence to strict safety and registration guidelines. Additionally, recipients must maintain active SAM and UEI registrations and comply with federal cybersecurity incident reporting requirements, including notifying the HHS of any breaches within 48 hours.
Department of Health and Human Services

POSTED

6 months ago

DEADLINE

in 5 months
View Details
NAICS: 541715
SBIR / STTR
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Solicitation # PA-27-100
The NIH, CDC, and FDA Small Business Innovation Research (SBIR) Grant, solicitation PA-27-100, provides early-stage funding to United States small business concerns (SBCs) to conduct research and development for commercial products. The program is structured in phases, with Phase I focusing on technical merit and feasibility and Phase II advancing the technology toward commercialization. Eligible applicants include for-profit U.S. businesses with no more than 500 employees. The funding opportunity accepts Phase I, Phase II, Direct to Phase II, and Fast-Track applications, with budget limits varying by participating institute, typically ranging from 400,000 to 700,000 dollars for Phase I and up to 3,000,000 dollars for Phase II. Applications are evaluated through a peer review system based on scientific and technical merit, significance, and the suitability of the business environment. While clinical trials are generally optional, they are prohibited for specific components, including all FDA participating components and several NIH institutes. Recipients must adhere to strict compliance requirements, including maintaining active SAM registration, disclosing foreign relationships, and implementing cybersecurity incident reporting procedures that notify agencies within 48 hours of discovery. The current solicitation remains open for applications until April 6, 2027.
Department of Health and Human Services

POSTED

6 months ago

DEADLINE

in 5 months
View Details
NAICS: 541715
SBIR / STTR
SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Solicitation # PAR-27-098
The SBIR/STTR Commercialization Readiness Pilot (CRP) Program, under solicitation PAR-27-098, is a funding opportunity provided by the National Institutes of Health (NIH) to help U.S.-based small business concerns transition technology from late-stage development to full commercialization. This program specifically targets recipients of prior active or ended NIH SBIR/STTR Phase II or Phase IIB Strategic Breakthrough awards. The CRP supports activities that bridge the gap to market, including late-stage research and development, independent replication of key studies, manufacturing scale-up, and technical assistance such as regulatory strategy, intellectual property planning, and market research. While significant outsourcing to contract research organizations is permitted, the small business must maintain a substantial role in project oversight and management. Eligible projects may have a maximum performance period of three years, with budget ceilings varying by the participating NIH Institute or Center, ranging from 500,000 dollars to 2 million dollars, or following SBA guidelines for certain institutes. Applications are evaluated via the NIH peer review system based on scientific and technical merit, commercial potential, and relevance to program priorities. Key requirements for applicants include maintaining active SAM and UEI registrations and submitting a detailed regulatory plan and progress report. It is important to note that while clinical trials are generally optional, several NIH components, including the NHLBI, NIAID, and NIDDK, do not accept clinical trials under this specific funding opportunity. Additionally, funds cannot be used for patent or FDA filing fees, nor can they include separate Technical and Business Assistance funding.
Department of Health and Human Services

POSTED

6 months ago

DEADLINE

in 5 months
View Details